Current Law Journal Content
Washington & Lee Law School
Current Law Journal Content
an index to legal periodicals
Bio-Science Law Review
Volume 10, Issue 4, 2009
DRUG REPURPOSING AND REPATENTING
DUNCAN CURLEY and AMANDA EASEY
Sometimes, an 'old' pharmaceutical compound may be discovered to have new medical uses. The patent claims to the chemical structure of the compound per se may already have expired by the time that such 'drug repurposing' is explored. Potent protection for the new invention must therefore involve a claim to second or further medical indications ('Swiss form' patent claims). This article discusses the legal protection options for repurposed drugs in Europe, including a review of the current status of second and further medical use claims and the availability of supplementary protection.
LIFE-SCIENCES, GENETIC ENGINEERING AND PATENT RIGHTS: A SINGAPORE PERSPECTIVE
Singapore has identified life science research as an important component of her economic and industrial growth strategy for her next phase of development. Not only is there strong Government support to encourage foreign biotechnology companies to locate in Singapore - there has also been on acute awareness of the need for discussion over regulation. The work of the Singapore Bioethics Advisory Committee in this area is particularly instructive and it can only be a question of time before the Singapore Patents System is asked to address issues on the interface between morality and patentability. This article surveys recent patent law developments in UK and Europe (and especially with reference to stem cells) and suggests that outside of the patent system, core regulation of the type of life science research to be permitted is best found outside of the patent system. Singapore is likely to adopt a light touch approach at least so far as patent law is concerned.
LATEST REFORM OF THE FRENCH INTELLECTUAL PROPERTY CODE: HARMONISATION WITH THE PATENT LAW TREATY
The French Intellectual Property Code has been substantively modified over the course of 2008 in order to harmonize it with the Patent Law Treaty. Moreover, the changes made in the potent section of the IPC are quite similar to those introduced in the 2000 European Patent Convention in December 2007. In particular, the changes relate to 1) simplification of the filing requirements. 2) introduction and precisions regarding the limitation procedure, and 3) precisions concerning restoration of rights for the patentee".
GERMANY - Patents - Adoption of amended Patent Law Bill UNITED KINGDOM - House of Lords on Genomic Medicine - Contracts insolvency ECJ - Ruling on SPC's
PATENTING LIVES, LIFE PATENTS, CULTURE AND DEVELOPMENT - JOHANNA GIBSON (ED.)